Vaccine Research & Development

Resources

Below are selected links to information about completed and ongoing clinical trials, studies, and news about our vaccine development work.

Clinical Trials

Marburg and Sudan Ebolavirus

Phase 1b Marburg and Sudan vaccine trial (Uganda)

Phase 1b Marburg and Sudan vaccine trial (U.S.)

Marburg Vaccine Trials

Phase 1 Marburg virus vaccine trial (U.S.) | Results

Phase 2 Marburg virus vaccine trial (Uganda and Kenya) (clinicaltrials.gov)

Phase 2 Marburg virus vaccine trial (Uganda and Kenya) (Pan African trials registry)

Phase 2 Marburg virus vaccine trial (Rwanda) (Pan African trials registry)

Phase 2 Marburg virus vaccine trial (U.S.)

Sudan Ebola Vaccine Trials

Phase 1 Sudan ebolavirus vaccine trial (Uganda) | Results

Phase 2 Sudan ebolavirus vaccine trial (Uganda and Kenya) (clinicaltrials.gov)

Phase 2 Sudan ebolavirus vaccine trial (Uganda and Kenya) (Pan African trials registry)

Factsheets

Marburg virus factsheet

Sudan ebolavirus factsheet

Findings, Studies, and Publications

National Institutes of Health: Marburg vaccine shows promising results in first-in-human study

Lancet Infectious Diseases, 2023: Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial

Sabin-Aspen Vaccine Science & Policy Group: Powering Vaccine R&D: Opportunities for Transformation

BARDA: BARDA continues partnership with Sabin for two filovirus vaccines

Sabin R&D News: For the latest on our vaccine development